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        Introduction 
  Integrin-mediated interactions between the extracellular matrix 
and the actin cytoskeleton play a central role in regulating cell 
migration in both normal and pathological processes, such as 
tumor metastasis. Many adherent cell types, such as fi  broblasts, 
form integrin-mediated adhesions, known as focal adhesions, 
that undergo cycles of assembly and disassembly during cell 
migration. Focal adhesions are generally found in less motile 
cells and function to tether actin-containing stress fi  bers. In con-
trast, motile and invasive cells, including myeloid cells and in-
vasive cancer cells, frequently form specialized integrin-mediated 
adhesive structures known as podosomes or matrix-degrading 
invadopodia (  Buccione et al., 2004  ;   Linder, 2007  ). Dynamic 
regulation of invadopodia in carcinoma cells is likely critical for 
the invasive capacity of metastatic cancer cells. However, an 
understanding of the mechanisms that regulate invadopodia 
dynamics in cancer cells remains limited. 
 First  identifi  ed in fi  broblasts transformed with the Rous-
sarcoma virus v-Src oncogene (  Tarone et al., 1985  ), podosomes 
and invadopodia contain many of the cytoskeletal and signaling 
proteins found in focal adhesions, including talin, vinculin, 
and paxillin (  Linder and Aepfelbacher, 2003  ). In contrast to 
focal adhesions, podosomes and invadopodia are not asso    -
ciated with stress fi  bers but instead contain several actin regu-
latory proteins, including cortactin, gelsolin, Wiskott-Aldrich 
syndrome protein, and the actin-nucleating Arp 2/3 complex 
(  Buccione et al., 2004  ). Furthermore, a hallmark of the invasive 
podosomes or invadopodia formed in metastatic cancer cells is 
the capacity for matrix degradation through the localized secre-
tion of ECM-degrading matrix metalloproteases (  Linder and 
Aepfelbacher, 2003  ). 
  There has been substantial recent progress in defi  ning 
the molecular mechanisms that regulate podosome dynamics 
(  Calle et al., 2004  ;   Yamaguchi and Condeelis, 2007  ). For ex-
ample, Src tyrosine kinases and the actin-binding protein 
cortactin are critical regulators of podosome formation and 
turnover (  Luxenburg et al., 2006  ). The intracellular, calcium-
dependent, thiol proteases calpains have also recently been 
implicated in regulating podosome disassembly in dendritic 
  I
nvasive cancer cells form dynamic adhesive structures 
associated with matrix degradation called invadopo-
dia. Calpain 2 is a calcium-dependent intracellular 
protease that regulates adhesion turnover and disassem-
bly through the targeting of speciﬁ  c substrates such as 
talin. Here, we describe a novel function for calpain 2 in 
the formation of invadopodia and in the invasive abilities 
of breast cancer cells through the modulation of endoge-
nous c-Src activity. Calpain-deﬁ  cient breast cancer cells 
show impaired invadopodia formation that is rescued by 
expression of a truncated fragment of protein tyrosine 
phosphatase 1B (PTP1B) corresponding to the calpain 
proteolytic fragment, which indicates that calpain modu-
lates invadopodia through PTP1B. Moreover, PTP1B ac-
tivity is required for efﬁ  cient invadopodia formation and 
breast cancer invasion, which suggests that PTP1B may 
modulate breast cancer progression through its effects 
on invadopodia. Collectively, our experiments implicate 
a novel signaling pathway involving calpain 2, PTP1B, 
and Src in the regulation of invadopodia and breast can-
cer invasion.
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  Results 
  Calpain 2 is necessary for invadopodia 
formation and invasion 
  Previous studies have demonstrated that the highly metastatic 
rat mammary adenocarcinoma (MTLn3) cells form invadopodia 
when plated on fi  bronectin (FN)- or gelatin-coated dishes and 
that the formation of these structures correlates with their meta-
static potential (  Yamaguchi et al., 2005  ). Calpains have been 
implicated in cancer cell migration and invasion (  Mamoune 
et al., 2003  ;   Libertini et al., 2005  ;   Carragher et al., 2006  ). To de-
termine if invadopodia formation is affected by calpain 2 ex-
pression, calpain 2  –  defi  cient MTLn3 cell lines were generated 
using RNA interference (  Franco et al., 2004a  ). Using two differ-
ent targeting vectors, calpain 2 expression levels were reduced 
to     30% of control MTLn3 cells, and invadopodia formation 
was assayed in control and calpain 2  –  defi  cient MTLn3 cells 
plated on FN or FN-coated gelatin substrates (  Fig. 1 A  ).    Inter-
estingly, we observed a signifi  cant reduction in the number 
of invadopodia formed in calpain 2  –  defi  cient MTLn3 cells on 
both FN and FN-coated gelatin (  Fig. 1 A  ). To confi  rm that the 
actin and cortactin-containing structures represent membrane 
projections on the ventral cell surface, confocal imaging was 
performed. Accordingly, the formation of invadopodia on the 
ventral cell surface was impaired in the calpain 2  –  defi  cient cell 
lines as compared with control cells by confocal imaging ( Fig. 1 B ). 
Calpain inhibition with cell-permeable calpain inhibitors also 
cells (  Calle et al., 2006  ) and osteoclasts (  Marzia et al., 2006  ). 
Calpains cleave many adhesion-associated and actin regula-
tory proteins including talin, FAK, paxillin, cortactin, and 
protein tyrosine phosphatase 1B (PTP1B;   Frangioni et al., 
1993  ;   Franco and Huttenlocher, 2005  ). PTP1B is a key posi-
tive regulator of Src kinase activity (  Bjorge et al., 2000  ) and 
is expressed at elevated levels in several human cancers 
(  Bentires-Alj and Neel, 2007  ). 
  Our previous studies have demonstrated roles for cal-
pains in the disassembly of focal adhesions in fi  broblasts 
through the limited proteolysis of the cytoskeletal protein talin 
(  Franco et al., 2004b  ). In addition to its role in adhesion dis-
assembly, recent evidence suggests a critical role for calpain in 
cell migration through the regulation of membrane protrusion 
(  Franco et al., 2004a  ;   Nuzzi et al., 2007  ). Furthermore, the 
ubiquitous calpain isoform calpain 2 is up-regulated in breast 
cancer and its expression correlates with increased invasive 
properties of tumors (  Libertini et al., 2005  ). However, the 
mechanism of calpain effects on cancer cell invasion or its role 
in regulating invadopodia dynamics in cancer cells has not 
been previously explored. 
  In this study, we examined the role of calpains in 
invadopodia formation and dynamics in the invasive breast 
adenocarcinoma MTLn3 cell line. Our fi  ndings  implicate 
a novel signaling pathway involving calpain 2, PTP1B, and 
Src in the regulation of invadopodia dynamics and breast cancer 
cell invasion. 
  Figure 1.       Calpain is necessary for invadopodia formation.   (A) Cell lysates from MTLn3 cells stably expressing control or calpain 2 siRNA were analyzed 
by Western blotting and probed for calpain 2 and actin as a loading control. MTLn3 cells expressing control or calpain 2si (targets A and B) were cultured 
on FN-coated glass coverslips and stained with anti-cortactin antibody (green) and rhodamine phalloidin (red). Quantiﬁ  cation of cortactin and actin con-
taining invadopodia is expressed as the mean number of invadopodia per cell for FN-coated and gelatin/FN-coated coverslips. Data are mean   ±   SEM of 
three independent experiments. *, P   <   0.05 compared with control cells. Bar, 10   μ  m. (B) Confocal images demonstrate actin (red) and cortactin (green) 
staining at protrusive structures on the ventral cell surface of control or calpain 2 si cells.     959 INVADOPODIA REGULATION BY CALPAIN, PTP1B, SRC   •   CORTESIO ET AL.
  Time-lapse analysis of invadopodia dynamics 
in calpain 2  –  deﬁ  cient MTLn3 cells 
  Previous studies have implicated calpain 2 in the turnover of 
focal adhesions in fi  broblast-like cells (  Bhatt and Huttenlocher, 
2003  ;   Franco et al., 2004b  ) and podosomes in osteoclasts (  Marzia 
et al., 2006  ) and dendritic cells (  Calle et al., 2006  ). To determine 
the effect of calpain 2 on invadopodia dynamics in MTLn3 cells, 
time-lapse microscopy was performed using control and calpain 2 –
 defi  cient MTLn3 cells that express the invadopodia markers 
GFP-cortactin or GFP-actin. Calpain 2  –  defi  cient cells formed 
less GFP-cortactin or GFP-actin containing invadopodia than 
control cells despite similar effi  ciency of transgene expression 
(  Figs. 3   and S1, available at http://www.jcb.org/cgi/content/
full/jcb.200708048/DC1).    Although the number of invadopodia 
was reduced, there were suffi  cient numbers of invadopodia in 
calpain 2  –  defi  cient cell lines to assay their dynamics. Live fl  uor-
escence imaging of GFP-actin or GFP-cortactin in these cells 
revealed the persistence of actin and cortactin in invadopodia for 
extended durations in calpain 2  –  defi  cient cells as compared with 
control cells with cells plated on FN ( Fig. 3, A and B ; and Videos 
1  –  4) or FN-coated gelatin (not depicted). Plots of GFP-actin or 
impaired invadopodia formation (unpublished data), which 
suggests that calpain protease activity is necessary for invado-
podia formation. 
  To determine if calpain is required for matrix degradation, 
calpain-defi  cient cells were plated on Oregon green 488 – labeled 
gelatin-coated coverslips. The cortactin-containing structures 
generally associated with sites of matrix degradation in control 
cells, which suggests that the majority of cortactin-containing 
dotlike structures in MTLn3 cells represent invadopodia (  Fig. 2 A  ).    
The formation of invadopodia was signifi  cantly impaired in 
the calpain 2  –  defi  cient cells, although the few structures that 
formed in calpain-defi  cient cells retained their matrix degrading 
function (  Fig. 2 A   and not depicted). To further assess the inva-
sive potential of calpain 2  –  defi  cient breast cancer cells, both 
calpain 2  –  defi  cient cell lines were plated on Matrigel-coated 
membranes and assayed for their ability to invade through the 
membrane. Both calpain 2  –  defi  cient cell lines demonstrated a 
signifi  cant reduction (approximately twofold) in invasiveness as 
compared with control cells (  Fig. 2 B  ). Together, these fi  ndings 
suggest that calpain 2 is important for both the formation of in-
vadopodia and invasive capacity of breast cancer cells. 
  Figure 2.       Calpain 2 is required for ECM degradation and invasion.   (A) MTLn3 cells expressing control or calpain 2 siRNA were cultured on Oregon green 
488 gelatin  –  coated coverslips and stained with anti-cortactin antibody. Arrows indicate areas of degradation that colocalize with cortactin containing 
invadopodia. Quantiﬁ  cation of the percentage of cells containing any ECM-degrading invadopodia is shown. Data are mean   ±   SEM of three independent 
experiments. *, P   <   0.02 compared with control cells. (B) MTLn3 cells expressing control or calpain 2si were plated on Matrigel-coated membranes and 
assayed for their ability to invade through the membrane. Invasion is shown relative to control cells. Data are mean   ±   SEM of three independent experi-
ments. *, P   <   0.04 compared with control cells. Bars: (A) 10   μ  m; (B) 1mm.     JCB • VOLUME 180 • NUMBER 5 • 2008  960
mutant form of cortactin, GFP  –  cortactin D28, which is resistant 
to calpain-mediated proteolysis (  Perrin et al., 2006  ). Cortactin-
defi  cient MTLn3 cells were generated using RNA interference 
with two different targeting vectors that reduced cortactin ex-
pression to     20% of control cells (  Fig. 4  ).    In accordance with 
previous studies (  Clark et al., 2007  ;   Webb et al., 2007  ), invado-
podia formation was impaired in cortactin-defi  cient MTLn3 
cells that express cortactin-specifi  c siRNA targets as compared 
with control siRNA (  Fig. 4 A  ). Both wild-type and calpain-
resistant GFP  –  cortactin D28 rescued invadopodia formation 
in cortactin-defi  cient MTLn3 cells, indicating that calpain-
mediated proteolysis of cortactin is not necessary for the forma-
tion of invadopodia (  Fig. 4 B  ). This rescue was confi  rmed by 
staining for both actin and Arp 2/3 invadopodia markers (  Figs. 
4 B   and S2, available at http://www.jcb.org/cgi/content/full/jcb
.200708048/DC1). These fi  ndings suggest that calpain 2 regu-
lates invadopodia formation independent of its effects on cor-
tactin proteolysis. 
  To determine if cortactin proteolysis regulates its dy-
namics at invadopodia, live fl  uorescence imaging was performed 
using cortactin-defi  cient MTLn3 cells that express either GFP-
cortactin or GFP  –  cortactin D28. Live imaging revealed that 
calpain-resistant cortactin, GFP  –  cortactin D28, persisted at 
GFP-cortactin fl  uorescence intensity as a function of time were 
used to calculate rate constants for invadopodia assembly and 
disassembly (  Fig. 3, A and B  ). Control cells formed invadopodia 
with dynamics that were similar to those in previously published 
studies (  Buccione et al., 2004  ;   Yamaguchi et al., 2005  ). In con-
trast, we found that the mean rates of assembly and disassembly 
of invadopodia were decreased in calpain 2  –  deficient cells 
(  Fig. 3, A and B  ). For the purposes of our study, we quantifi  ed 
the dynamics of short-lived precursor invadopodia, although simi-
lar calpain effects were observed with long-lived invadopodia 
(unpublished data). Interestingly, our fi  ndings suggest a novel 
role for calpain 2 in regulating assembly of invadopodia with a 
greater than twofold reduction in assembly rates of invadopodia 
in calpain 2  –  defi  cient cells (  Fig. 3  ). Together, these fi  ndings in-
dicate that calpain 2 is required for both the effi  cient assembly 
and disassembly of invadopodia. 
  Expression of a calpain 2  –  resistant 
cortactin impairs invadopodia disassembly 
  Previous studies have implicated direct proteolysis of cortactin 
by calpain 2 in the regulation of membrane protrusion dynamics 
(  Perrin et al., 2006  ). To determine if the direct proteolysis of 
cortactin modulates the formation of invadopodia, we used a 
  Figure 3.       Invadopodia assembly and disassembly rates are reduced in calpain 2  –  deﬁ  cient MTLn3 cells.   (A) GFP-actin or (B) GFP-cortactin were transiently 
transfected into MTLn3 control and calpain 2 siRNA lines. Cells were plated on FN-coated glass-bottomed dishes and analyzed by time-lapse ﬂ  uorescence 
microscopy. The time-lapse montage of calpain-deﬁ  cient cells expressing GFP-actin (A) or GFP-cortactin (B) demonstrates that GFP-actin or GFP-cortactin 
persist at invadopodia for longer durations in calpain-deﬁ  cient MTLn3 cells. Arrows indicate representative invadopodia. Duration measurements and as-
sembly and disassembly rates are shown. Data show means   ±   SEM from four independent experiments. Asterisks indicate statistical signiﬁ  cance compared 
with control based on a   t   test (*, P   <   0.03; **, P   <   0.05). See Videos 1  –  4 (available at http://www.jcb.org/cgi/content/full/jcb.200708048/DC1). 
Bars, 10   μ  m.     961 INVADOPODIA REGULATION BY CALPAIN, PTP1B, SRC   •   CORTESIO ET AL.
  Figure 4.       Calpain 2  –  mediated proteolysis of cortactin is not necessary for invadopodia formation but mediates disassembly of cortactin from invadopodia.   
(A) Cell lysates from MTLn3 cells stably expressing control or cortactin siRNA were analyzed by Western blotting and probed for cortactin and ERK as a 
loading control. MTLn3 cells expressing control or cortactin siRNA were cultured on gelatin/FN-coated coverslips and stained with anti  –  p34-Arc antibody 
and rhodamine phalloidin. Quantiﬁ  cation of invadopodia is expressed as the mean number of invadopodia per cell. *, P   <   0.05 compared with control 
cells. (B) Wild-type (WT) or calpain-resistant (D28) GFP-cortactin was transiently transfected into MTLn3 control and cortactin siRNA lines, cultured on gelatin/
FN-coated coverslips, and stained with rhodamine phalloidin. Quantiﬁ  cation of invadopodia is expressed as the mean number of invadopodia per cell. 
*, P   <   0.05 compared with control cells. (C) GFP-cortactin WT or GFP-cortactin D28 expressing cells were plated on FN-coated glass-bottomed dishes and 
analyzed by time-lapse microscopy. Time-lapse montage of cortactin-deﬁ  cient MTLn3 cells expressing GFP-cortactin WT or GFP-cortactin D28 demonstrates 
that GFP-cortactin D28 persists at invadopodia for longer durations than GFP-cortactin WT. Duration measurements and assembly and disassembly rates 
are shown. Arrows indicate representative invadopodia. Asterisk indicates statistical signiﬁ  cance based on   t   test (P   <   0.01). See Videos 5 and 6 (available 
at http://www.jcb.org/cgi/content/full/jcb.200708048/DC1). Data are means   ±   SEM from three independent experiments. Bars, 10   μ  m.     JCB • VOLUME 180 • NUMBER 5 • 2008  962
control MTLn3 cells transformed with v-Src (  Fig. 5 A  ).    Surpris-
ingly, there was no signifi  cant difference in invadopodia num-
bers in v-Src transformed calpain 2  –  defi   cient MTLn3 cells 
compared with v-Src transformed control cells, indicating that 
calpain 2 is not required for invadopodia formation downstream 
of v-Src (  Fig. 5 A  ). Expression of a constitutively active c-Src 
Y527F but not wild-type c-Src also rescued invadopodia forma-
tion (Fig. S4). Together, these fi  ndings suggest that calpain 2 
functions upstream of c-Src kinase to regulate invadopodia for-
mation in MTLn3 breast cancer cells but is not necessary for in-
vadopodia formation in the context of v-Src transformed cells. 
  To further elucidate how calpain 2 affects invadopodia 
dynamics in v-Src transformed MTLn3 cells, time-lapse micros-
copy was performed using control and calpain 2  –  defi  cient v-Src 
transformed MTLn3 cells. Live fl  uorescent imaging of GFP-
 cortactin in these cells demonstrated enhanced invadopodia assem-
bly in v-Src transformed cells in agreement with previous studies 
(  Tarone et al., 1985  ;   Tatin et al., 2006  ). However, the duration of 
invadopodia was enhanced approximately twofold in calpain 2  –
 defi  cient cells transformed with v-Src, which suggests that, al-
though calpain 2 is not necessary for invadopodia formation, 
it modulates invadopodia turnover in v-Src transformed cells. 
Accordingly, invadopodia assembly rates in v-Src transformed 
control and calpain 2  –  defi  cient cells were found to be approx-
imately equal (  Fig. 5 B  ). However, disassembly rates of invado-
podia were reduced approximately twofold in calpain 2 – defi  cient 
as compared with control v-Src transformed cells. Furthermore, 
our fi  ndings implicate cortactin proteolysis downstream of v-Src 
  Figure 5.       Calpain 2 regulates invadopodia 
dynamics downstream of transforming v-Src 
kinase in MTLn3 breast cancer cells.   (A) Control 
and calpain 2 knockdown MTLn3 cells express-
ing v-Src kinase were cultured on FN-coated 
glass coverslips and stained with anti-cortactin 
antibody and rhodamine phalloidin. Quantiﬁ  -
cation of cortactin and actin containing inva-
dopodia is expressed as the mean number of 
invadopodia per cell. Data shown are means   ±   
SEM of three independent experi  ments. (B) GFP-
cortactin was transfected into v-Src transformed 
MTLn3 control or calpain 2 siRNA lines. Cells 
were plated on FN-coated glass-bottomed dishes 
and analyzed by time-lapse ﬂ  uorescence micros-
copy. Fluorescent images of v-Src transformed 
control or calpain 2  –  deﬁ  cient cells demonstrate 
that GFP-cortactin persists at invadopodia for 
longer durations in the absence of calpain 2. 
Arrows indicate representative GFP-cortactin 
containing invadopodia. Duration measurements 
and assembly and disassembly rates   ±   SEM 
are shown. Asterisks indicate statistical signiﬁ  -
cance compared with control cells based on 
  t   test (P   <   0.05). See Videos 7 and 8 (available 
at http://www.jcb.org/cgi/content/full/jcb
.200708048/DC1). Bars, 10   μ  m.     
invadopodia approximately twice as long as wild-type GFP-
cortactin (  Fig. 4 C   and Videos 5 and 6, available at http://www
.jcb.org/cgi/content/full/jcb.200708048/DC1). We measured 
assembly and disassembly rates of wild-type GFP-cortactin and 
GFP  –  cortactin D28 at invadopodia and found that although 
assembly rates were slightly decreased, the rate of invadopodia 
disassembly was reduced approximately twofold with GFP  – 
cortactin D28 as compared with wild-type GFP-cortactin ( Fig. 4 C ). 
These fi  ndings suggest that cortactin proteolysis is necessary for 
its effi  cient disassembly from invadopodia. Furthermore, these 
results suggest, in a manner analogous to the role of calpain 
proteolysis of talin in focal adhesion disassembly (  Franco et al., 
2004b  ), that calpain proteolysis of cortactin may be an important 
mechanism by which invadopodia are disassembled. 
  Calpain 2 functions both upstream and 
downstream of Src to regulate invadopodia 
  Previous studies indicate that Src tyrosine kinases function at 
an early step in the formation of podosomes and invadopodia. 
Accordingly, we found that Src activity was necessary for invado-
podia formation in MTLn3 cells because the Src inhibitor PP2 
impaired invadopodia formation (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200708048/DC1). To address 
whether calpain functions upstream or downstream of Src tyro-
sine kinases, we determined if calpain 2 was required for inva-
dopodia formation in cells that express constitutively active 
v-Src. In accordance with previous publications, there was a 
substantial increase in the number of invadopodia formed in 963 INVADOPODIA REGULATION BY CALPAIN, PTP1B, SRC   •   CORTESIO ET AL.
hypothesis that calpain 2 functions upstream of c-Src to regulate 
Src activity and thereby invadopodia formation in MTLn3 cells. 
  An attractive candidate to mediate calpain effects on Src 
activity is PTP1B, a known calpain substrate. Previous studies 
have reported that PTP1B activates endogenous c-Src in breast 
cancer cells by the dephosphorylation of its inhibitory tyrosine 
529 (  Bjorge et al., 2000  ). Accordingly, it has been reported 
that the cell-permeable, PTP1B inhibitor compound II (CII) 
enhances phosphorylation of tyrosine 529 and reduces c-Src 
activity (  Liang et al., 2005  ). We also found that the PTP1B in-
hibitor CII increased phosphorylation at tyrosine 529 using 
a phospho-specifi  c antibody that detects phosphorylation at 
tyrosine 529. The increase in phosphorylation at tyrosine 529 
was only modest with an     1.4-fold increase compared with 
vehicle control-treated cells (  Fig. 6 B  ). However, these modest 
in invadopodia disassembly (Fig. S5 and not depicted). Collec-
tively, these data suggest that calpain 2 functions downstream of 
Src to regulate invadopodia dynamics and disassembly at least in 
part through cortactin proteolysis. Furthermore, our fi  ndings 
also implicate a novel role for calpain 2 in invadopodia forma-
tion upstream of c-Src. 
  Calpain and PTP1B modulate c-Src activity 
  To determine if calpain 2 regulates endogenous c-Src kinase activ-
ity in MTLn3 cells, c-Src expression and activity were analyzed in 
calpain 2  –  defi  cient cells. There was no difference in expression 
of endogenous c-Src in control and calpain 2  –  defi  cient MTLn3 
cells (  Fig. 6 A  ).    However, adhesion-induced c-Src activity was de-
creased by approximately twofold in calpain 2  –  defi  cient cell lines 
compared with control cells (  Fig. 6 A  ). These fi  ndings support the 
  Figure 6.       Calpain 2 and PTP1B regulate Src kinase activity and phosphorylation on tyrosine 529 in MTLn3 breast cancer cells.   (A) Lysates from MTLn3 cells 
expressing control or calpain 2 siRNA were probed for total Src expression. Immunoprecipitations were performed on lysates from MTLn3 cells stably ex-
pressing control or calpain 2 siRNA using Src-speciﬁ  c antibodies. Kinase activity assays were performed and the autoradiograph is shown. Quantiﬁ  cation 
of Src activity relative to total Src in either control or calpain 2si lysates from three separate experiments   ±   SEM is shown. Asterisks indicate statistical sig-
niﬁ  cance compared with control based on   t   test (P   <   0.01). (B) MTLn3 cells stably expressing control or calpain 2 siRNA were analyzed by immunoblotting 
and probed for total Src and phospho-Y529. As a positive control, wild-type MTLn3 cells were treated with 200 nM CII, a cell-permeable PTP1B inhibitor, 
or vehicle before lysis. Quantiﬁ  cation of phospho-Y529 levels normalized to total Src   ±   SEM of three independent experiments is shown. Asterisks indicate 
statistical signiﬁ  cance compared with control based on one-way ANOVA (P   <   0.05). (C) Cell lysates from MTLn3 cells stably expressing control or PTP1B 
siRNA were analyzed by Western blotting and probed for calpain 2 and vinculin as a loading control. PTP1Bsi cell lysates were analyzed by immunoblot 
and probed for total Src and phospho-Y529. Quantiﬁ  cation of phospho-Y529 levels normalized to total Src   ±   SEM of three independent experiments is 
shown. Asterisks indicate statistical signiﬁ  cance compared with control based on one-way ANOVA (P   <   0.05). (D) Src expression was analyzed by West-
ern blotting in control and PTP1Bsi cells. Immunoprecipitations were performed as described in A on PTP1Bsi cells. Kinase activity assays were performed 
and the autoradiograph is shown. Quantiﬁ  cation of Src activity relative to total Src in either control or PTP1Bsi lysate from three separate experiments is 
shown as the means   ±   SEM. The asterisk indicates statistical signiﬁ  cance compared with control based on a   t   test (P   <   0.05). Numbers to the left of gel 
blots indicate molecular mass standards in kD.     JCB • VOLUME 180 • NUMBER 5 • 2008  964
using the widely used phosphatase substrate paranitrophenyl 
phosphate (pNPP) as described previously (  Peters et al., 2003  ). 
In agreement with previously published reports, the His-tagged 
PTP1B truncations demonstrated enhanced phosphatase activity 
compared with full-length PTP1B in vitro (  Fig. 7 A  ;   Frangioni 
et al., 1993  ). To further characterize the effects of calpain proteol-
ysis on PTP1B activity in vitro, both the full-length PTP1B and 
the truncation mutants were treated with purifi  ed calpain 2 and 
assayed for phosphatase activity. Calpain 2 enhanced the activ-
ity of full-length PTP1B by     1.7-fold but had no effect on 
the activity of the truncation mutants, which further supports a 
role for calpain proteolysis in the regulation of PTP1B activity 
(  Fig. 7 B  ). This enhancement in PTP1B activity required the 
presence of calcium and was blocked by the calpain inhibitor 
ALLM (  Fig. 7 B  ). 
  Truncated PTP1B rescues invadopodia 
formation in calpain 2  –  deﬁ  cient cells 
  To determine if PTP1B is cleaved by calpain 2 in vivo, we exoge-
nously expressed a tagged form of PTP1B in control or calpain 2  – 
deficient HEK-293 cells. Human embryonic kidney (HEK) 
cells were used to obtain high levels of exogenously expressed 
PTP1B to facilitate observation of calpain 2  –  mediated cleavage. 
We observed substantial proteolysis of exogenously expressed 
GFP-PTP1B-HA in control but not calpain 2  –  defi  cient HEK cells 
( Fig.  8  A ).   Cell lysates isolated from control HEK cells treated 
with ionomycin generated a proteolytic fragment     8 kD smaller 
than the full-length, tagged PTP1B (  Fig. 8 A  ). Similarly, we ob-
served modest proteolysis of exogenously expressed FLAG-PTP1B 
in control MTLn3 cells and decreased PTP1B proteolysis in both 
calpain 2  –  defi  cient cell lines (  Fig. 8 B  ). To determine if calpain 2 
regulates PTP1B activity in MTLn3 cells, FLAG-PTP1B was 
immunoprecipitated from control or calpain-defi  cient MTLn3 
increases in phosphorylation are consistent with what has pre-
viously been found in other cell types with PTP1B inhibition 
(  Liang et al., 2005  ). To determine if calpain modulates phos-
phorylation at tyrosine 529, the calpain 2  –  defi  cient cell lines 
were tested. We found similar increases in phosphorylation at 
this inhibitory tyrosine with a 1.4  –  1.5-fold increase in phos-
phorylation, which suggests that calpain 2 may modulate Src 
activity through the regulation of PTP1B activity (  Fig. 6 B  ). 
  Previous studies have demonstrated that PTP1B regulates 
c-Src activity in breast cancer cells (  Bjorge et al., 2000  ). To deter-
mine if PTP1B also regulates the activity of endogenous c-Src in 
MTLn3 cells, PTP1B-defi  cient MTLn3 cell lines were generated 
using RNA interference (  Franco et al., 2004a  ). We had diffi  culty 
generating stable cell lines that were defi  cient in PTP1B but gen-
erated partial knockdown lines that had PTP1B levels reduced by 
40 – 50%  ( Fig.  6  C ).  PTP1B-defi  cient MTLn3 cells displayed en-
hanced phosphorylation at tyrosine 529 (  Fig. 6 C  ) and reduced 
activity of c-Src as compared with control cells (  Fig. 6 D  ). Col-
lectively, our fi  ndings indicate that both calpain 2 and PTP1B 
modulate Src phosphorylation at tyrosine 529 and regulate the 
activity of endogenous c-Src. 
  Calpain 2  –  mediated proteolysis of PTP1B 
results in enhanced phosphatase activity 
  Previous studies have reported that calpains cleave PTP1B in 
vivo (  Frangioni et al., 1993  ;   Ezumi et al., 1995  ) and enhance 
its phosphatase activity (  Frangioni et al., 1993  ). The putative 
calpain proteolytic site involves truncation of     8 kD from the 
C terminus of PTP1B between residues 360 and 381 (  Fig. 7 A  ).    
To examine the effects of calpain 2  –  mediated proteolysis on 
PTP1B activity, we generated full-length His-tagged PTP1B 
and His-tagged C-terminal truncations at amino acids 360 and 381 
( Fig.  7  A ).  Purifi  ed pools were assayed for phosphatase activity 
  Figure 7.       Calpain 2 proteolysis of PTP1B 
results in enhanced PTP1B activity.   (A) Sche-
matic of full-length and truncated His-tagged 
PTP1B constructs. The arrow indicates the ap-
proximate site of calpain 2 cleavage. Equal 
amounts of puriﬁ  ed PTP1B constructs were as-
sayed for phosphatase activity against pNPP 
as described in Materials and methods. Activ-
ity of truncated PTP1B constructs is expressed 
relative to the full-length protein. Activity data 
are shown as the means   ±   SEM from three sep-
arate experiments. Asterisks indicate statistical 
signiﬁ   cance compared with full-length PTP1B 
activity based on a   t   test (P   <   0.0001). (B) Puri-
ﬁ  ed full-length (FL) or PTP1B truncated at amino 
acid 381 were incubated in the presence or 
absence of puriﬁ  ed calpain 2 and assayed for 
phosphatase activity. The asterisk indicates sta-
tistical signiﬁ   cance compared with untreated 
PTP1B activity based on a   t   test (P   <   0.001). 
Error bars represent the SEM of at least three 
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truncation mutant were expressed in control or calpain 2 – defi  cient 
cells and assayed for invadopodia formation (  Fig. 8 C  ). In accor-
dance with our reported fi  ndings (  Fig. 1  ), calpain 2  –  defi  cient cells 
that expressed control GFP displayed impaired invadopodia for-
mation as compared with cells that express control siRNA. In con-
trast, calpain 2  –  defi  cient cells that expressed GFP-PTP1B 360 
showed a substantial increase in the number of invadopodia as 
compared with control cells (  Fig. 8 C  ). Together, these fi  ndings 
indicate that a truncated PTP1B, based on the predicted calpain 
proteolytic fragment, rescues invadopodia formation in calpain 2  –
 defi  cient MTLn3 cells. 
  PTP1B regulates invadopodia formation 
and breast cancer invasion 
  Recent studies implicate a critical role for PTP1B in breast 
cancer progression in mouse models (  Bentires-Alj and Neel, 
cells treated with ionomycin and assayed for phosphatase activity. 
Despite similar expression levels, FLAG-PTP1B activity was 
 signifi  cantly decreased in both calpain 2 knockdown cell lines 
compared with the control cells (  Fig. 8 B  ). This is the fi  rst study 
that indicates that calpain 2 is the likely isoform required for 
this proteolytic modifi  cation in vivo. These fi  ndings indicate that 
PTP1B is cleaved by calpain 2 in vivo, and this proteolytic modi-
fi  cation results in the generation of an activated form of PTP1B. 
This is especially intriguing in light of the role of PTP1B in acti-
vating c-Src in breast cancer cells by dephosphorylating the in-
hibitory tyrosine 529. 
 Our  fi  ndings indicate that calpain 2  –  mediated proteolysis of 
PTP1B results in an approximate 8-kD C-terminal truncation and 
enhanced phosphatase activity. To determine if this truncated form 
of PTP1B can rescue invadopodia formation in calpain 2  – 
defi  cient MTLn3 cells, GFP control or the GFP-tagged PTP1B 360 
  Figure 8.       Calpain 2 regulates PTP1B activity in vivo.   (A) HEK cells transfected with GFP-PTP1B-HA were analyzed by Western blot after treatment with 
vehicle or ionomycin to stimulate calpain activity and blotted for GFP, calpain 2, talin, and actin as a loading control. Blots shown are representative of 
three independent experiments. The arrow indicates a calpain 2  –  dependent PTP1B cleavage product. (B) FLAG-PTP1B was transiently transfected into 
MTLn3 control and calpain 2 siRNA lines. Immunoprecipitations were performed on cells expressing FLAG-PTP1B after treatment with ionomycin. Shown 
are the relative amounts of FLAG-PTP1B that were pulled down. The arrow with an asterisk indicates a calpain 2  –  dependent PTP1B cleavage product. 
Blots shown are representative of three independent experiments. PTP1B cleavage was quantiﬁ  ed for control and calpain 2 siRNA lines as a percentage 
of total FLAG-PTP1B expression and is shown relative to control cells. (left) Asterisks indicate statistical signiﬁ  cance compared with control cells based on 
one-way ANOVA (P   <   0.05). Immunoprecipitations were assayed for phosphatase activity against pNPP as described in Materials and methods. Activity of 
immunoprecipitated PTP1B constructs in MTLn3 calpain 2 siRNA lines is expressed relative to the control cell line. Activity data are shown as the means   ±   
SEM from three separate experiments. (right) Asterisks indicate statistical signiﬁ  cance based on a   t   test (P   <   0.002). (C) MTLn3 cells were transfected with 
GFP-PTP1B truncated at amino acid 360 or GFP alone. Transfected cells were plated on FN-coated glass coverslips and stained with anti-cortactin antibody. 
Invadopodia formation was quantiﬁ  ed by determining the mean number of invadopodia per cell. Data represent means   ±   SEM from three independent 
experiments. *, P   <   0.05 compared with GFP-expressing control cells. Bar, 10   μ  m.     JCB • VOLUME 180 • NUMBER 5 • 2008  966
Calpain inhibition resulted in extended durations of invado  podia 
(mean     17 min) and impaired both the dynamic assembly and 
disassembly of these structures. It has been suggested that 
precursor invadopodia are more motile on the ventral cell mem-
brane and that stabilization of invadopodia or decreased mobility 
is associated with enhanced matrix degradation (  Gimona and 
Buccione, 2006  ); however, no signifi  cant differences in invado-
podia mobility were observed between control and calpain 2  –
 defi  cient cells (unpublished data). This suggests that although 
calpain 2  –  defi  cient cells were signifi  cantly impaired in their 
ability to degrade matrix and invade through Matrigel, this de-
fect is likely a result of the inability of calpain 2  –  defi  cient cells 
to effi  ciently form invadopodia and not a defect in stabilization 
of precursor structures. 
  Previous studies have established a role for calpain prote-
ases in the turnover of integrin-mediated adhesions in migrating 
cells (  Huttenlocher et al., 1997  ;   Bhatt and Huttenlocher, 2003  ) 
with the specifi  c involvement of talin proteolysis in focal adhe-
sion disassembly (  Franco et al., 2004b  ). Recent progress has 
also implicated calpain protease activity in the regulation of 
podosome disassembly in dendritic cells (  Calle et al., 2006  ) 
and osteoclasts (  Marzia et al., 2006  ). However, in these studies, 
the involvement of specifi  c substrates was not demonstrated, al-
though several calpain substrates, including cortactin, Wiskott-
Aldrich syndrome protein, and Pyk2, have been shown to 
localize to podosomes (  Calle et al., 2006  ;   Linder, 2007  ). In this 
study, we show that calpain 2 is involved in the disassembly of 
invadopodia at least in part through the targeted proteolysis 
of cortactin. Although expression of cortactin is required for 
invadopodia assembly, calpain-resistant cortactin was able to 
rescue invadopodia formation in cortactin-defi  cient MTLn3 
cells, which suggests that calpain proteolysis of cortactin is not 
essential for the formation of invadopodia. However, expression 
of the calpain-resistant cortactin impaired the disassembly of 
cortactin from invadopodia, indicating that cortactin proteolysis 
is likely a mechanism by which invadopodia disassemble. Collec-
tively, our fi  ndings suggest that calpain 2 functions downstream 
of Src tyrosine kinases to regulate invadopodia disassembly 
through the targeted proteolysis of specifi  c effector substrates 
such as cortactin. 
  Substantial evidence has implicated calpain 2 in the 
  regulation of adhesion disassembly downstream of the trans-
forming oncogene v-Src. Studies by Carragher et al. (  2002  ) 
demonstrated that v-Src transformation induces the calpain-
dependent proteolysis of specifi  c substrates. In further studies, 
calpain 2 was demonstrated to be a critical effector down-
stream of v-Src in regulating adhesion disassembly, cell mor-
phology, and cell cycle progression (  Carragher et al., 2004  ). 
In agreement with these fi  ndings, invadopodia in v-Src trans-
formed calpain 2  –  defi  cient MTLn3 cells had substantially 
reduced disassembly rates but not assembly rates compared 
with control cells. The importance of cortactin proteolysis 
downstream of transforming v-Src is further supported by the 
impaired disassembly of calpain-resistant cortactin in v-Src 
transformed cells (unpublished data). It will be interesting to 
determine if cortactin proteolysis is also critical for calpain 
effects on the disassembly of podosomes in other cell types. 
2007  ;   Julien et al., 2007  ). To determine if PTP1B regulates 
breast cancer invasion, we tested the effects of PTP1B inhibi-
tion using a PTP1B inhibitor or PTP1B-defi  cient cell lines on 
the formation of invadopodia and invasion across Matrigel-
coated membranes. We found that invadopodia formation 
was impaired in MTLn3 cells treated with the cell-permeable 
PTP1B inhibitor CII (  Fig. 9 A  ).    In accordance with our fi  nd-
ings using CII, we found that invadopodia formation was also 
reduced approximately twofold in the PTP1B-defi  cient cell 
lines (  Fig. 9 B  ). To determine if PTP1B is required for inva-
sion, PTP1B-defi  cient cell lines were plated on Matrigel-coated 
membranes and assayed for their ability to migrate through the 
membrane. Despite only a 50% knockdown, the cell line most 
defi  cient in PTP1B exhibited a twofold inhibition of cell inva-
sion compared with control cells (  Fig. 9 C  ). Furthermore, treat-
ment with the PTP1B inhibitor CII also impaired invasion of 
MTLn3 breast cancer cells by approximately twofold (  Fig. 9 C  ). 
Together, the fi  ndings implicate PTP1B as a novel component 
of a signaling pathway that regulates invadopodia formation 
and invasion in breast cancer cells. 
  Discussion 
  Invasive cancer cells form dynamic protrusive structures known 
as invadopodia that are associated with ECM degradation and 
increased tumor cell invasiveness. Here, we describe a novel func-
tion for the intracellular, calcium-dependent protease calpain 2 
in the dynamic regulation of invadopodia both upstream and 
downstream of Src tyrosine kinases in metastatic breast cancer 
cells. Although calpains have been implicated in podosome 
turnover (  Calle et al., 2006  ;   Marzia et al., 2006  ), this is, to our 
knowledge, the fi  rst fi  nding that calpain 2 is necessary for the 
formation of invadopodia. We also provide evidence to suggest 
that calpain 2  –  mediated proteolysis and activation of PTP1B 
is an important mechanism by which calpain 2 regulates c-Src 
activity and invadopodia formation in breast cancer cells. Finally, 
our fi  ndings indicate that PTP1B is a novel component of the 
regulatory pathway that modulates invadopodia formation through 
the regulation of Src activity. Collectively, our fi  ndings identify 
a novel signaling pathway involving calpain 2, PTP1B, and Src 
that regulates invadopodia formation and invasion of metastatic 
breast cancer cells. 
  Both invadopodia and podosomes are dynamic, actin-
containing structures that share similar components but have been 
reported to have distinct kinetics and dynamics. Time-lapse 
analysis of invadopodia formation has shown that invadopodia, 
in contrast to podosomes, are formed de novo at the periphery 
of the cell with lifetimes that are generally longer than podo-
somes, ranging from minutes to hours (  Buccione et al., 2004  ; 
  Yamaguchi et al., 2005  ;   Gimona and Buccione, 2006  ). We per-
formed time-lapse microscopy of MTLn3 cells to characterize 
the dynamics of   “  short-lived  ”   invadopodia or podosome-like 
structures in MTLn3 breast cancer cells; however, calpain ef-
fects on assembly and disassembly of both   “  short-lived  ”   and 
 “ long-lived ”  structures were found to be similar (unpublished data). 
These structures displayed dynamic assembly and disassembly 
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and Marchisio, 2006  ) and that its activity is modulated down-
stream of integrin-mediated adhesion and by the activity of 
growth factor signaling pathways such as EGF receptor signaling. 
EGF receptor activation stimulates invadopodia formation and 
  In this work, we show that calpain 2 functions upstream of 
endogenous c-Src to positively regulate Src activity and invado-
podia formation. Previous studies have shown that Src activity 
is necessary for invadopodia formation (  Chen, 1989  ;   Spinardi 
  Figure 9.       PTP1B is necessary for efﬁ  cient invado-
podia formation and invasion.   (A) MTLn3 cells cul-
tured on FN-coated glass coverslips were stained 
with anti-cortactin antibody and rhodamine phal-
loidin. Cells were cultured in the presence of ve-
hicle or the cell-permeable PTP1B inhibitor CII. 
Quantiﬁ  cation of invadopodia is expressed as the 
mean number of invadopodia per cell. Data are 
mean   ±   SEM of three independent experiments. 
*, P   <   0.01 compared with control cells. (B) MTLn3 
cells expressing control or PTP1Bsi were cultured 
on FN-coated glass coverslips and stained with 
anti-cortactin antibody and rhodamine phalloidin. 
Quantiﬁ  cation of invadopodia is expressed as the 
mean number of invadopodia per cell. Data are 
mean   ±   SEM of three independent experiments. 
*, P   <   0.01 compared with control cells. (C, left) 
MTLn3 cells were cultured in the presence of 
vehicle or CII and assayed for their ability to in-
vade through the membrane. Invasion is shown 
relative to control cells. Data are mean   ±   SEM 
of three independent experiments. *, P   <   0.05. 
(right) MTLn3 cells expressing control or PTP1B 
siRNA were plated on Matrigel-coated membranes 
and assayed for their ability to invade through the 
membrane. Invasion is shown relative to control 
cells. Data are mean   ±   SEM of three independent 
experiments. *, P   <   0.02 compared with control 
cells. Bars: (A and B) 10   μ  m; (C) 1 mm.     JCB • VOLUME 180 • NUMBER 5 • 2008  968
has not been elucidated. Our fi  ndings implicate a role for PTP1B 
in the modulation of endogenous c-Src activity, providing an at-
tractive mode of action because elevated c-Src activity has been 
detected in many breast cancer cell lines (  Bjorge et al., 2000  ). 
Moreover, we provide evidence that PTP1B is a novel component 
of the signaling machinery involved in regulating invadopodia 
formation and breast cancer invasion. Together, these fi  ndings 
suggest that modulation of calpain 2/PTP1B function may pro-
vide a novel therapeutic target for breast cancer. The availability 
of cell-permeable calpain 2 and PTP1B inhibitors supports the 
utility of this approach. 
  In summary, our fi  ndings provide novel mechanistic insight 
into the functional roles of calpain 2/PTP1B/c-Src signaling in 
the formation of invadopodia in metastatic breast cancer cells. 
These fi  ndings support a critical role for regulated intracellular 
proteolysis by calpains functioning in concert with targeted phos-
phorylation/dephosphorylation events in the modulation of intra-
cellular signaling pathways through Src. Our fi  ndings indicate 
that calpains play critical roles both upstream and downstream of 
Src tyrosine kinases by targeting distinct substrates that modulate 
the formation and turnover of invadopodia (  Fig. 10  ).    It is likely 
that calpain effects are context dependent because calpain 2 is not 
necessary for invadopodia formation in breast cancer cells trans-
formed with v-Src. Furthermore, calpains target other substrates 
at invadopodia, including talin, that may also contribute to cal-
pain effects on invadopodia dynamics. Future studies should shed 
additional light on the role of this pathway in regulating the tem-
poral and spatial dynamics of invadopodia formation and matura-
tion into matrix-degrading structures that mediate breast cancer 
cell invasion and metastasis. 
invasion of MTLn3 cells (  Yamaguchi et al., 2005  ) and has also 
been reported to activate calpain 2 through an extracellular signal-
regulated kinase (ERK)-dependent pathway (  Glading et al., 
2002  ). We now provide direct evidence that calpain 2 may be a 
critical link between integrin and/or EGF receptor signaling 
and the activation of Src kinase activity in the formation of inva-
dopodia. Calpain 2 depletion by siRNA inhibited the activation 
of endogenous c-Src activity by integrin-mediated adhesion 
and impaired invadopodia formation in breast cancer cells. 
Furthermore, expression of activated v-Src or c-Src rescued 
invadopodia formation in calpain 2  –  defi  cient cells, which sug-
gests that calpain 2 functions upstream of Src to regulate invado-
podia formation. 
  We have identifi  ed a potential mechanism for calpain 2 
regulation of c-Src activity through the proteolysis of the ubiqui-
tously expressed tyrosine phosphatase PTP1B. PTP1B has been 
shown to interact with integrin complexes (  Arregui et al., 1998  ) 
and localizes to early cell matrix adhesion sites (  Hernandez 
et al., 2006  ). PTP1B can promote c-Src activation by the direct 
dephosphorylation of the inhibitory phosphate tyrosine 529 
(  Bjorge et al., 2000  ;   Liang et al., 2005  ). In contrast to c-Src, for 
which calpain 2  –  dependent proteolysis was not detected in vivo, 
PTP1B was proteolyzed in a calpain 2  –  dependent manner, re-
sulting in the generation of a stable PTP1B fragment that has en-
hanced phosphatase activity (  Frangioni et al., 1993  ). Accordingly, 
we found that calpain 2  –  defi  cient cells had increased phosphor-
ylation at the c-Src inhibitory tyrosine 529 that is regulated by 
PTP1B, and that a PTP1B fragment corresponding to the calpain 
proteolytic fragment rescued invadopodia formation in calpain 2  –
 defi  cient cells. It is interesting that we detected substantially 
enhanced phosphatase activity with the PTP1B truncations, 
which are similar in size to the calpain 2 cleavage fragment, and 
that this activity was not further modifi  ed by the activity of cal-
pain 2. These fi  ndings suggest that calpain 2 functions as a posi-
tive regulator of PTP1B activity. This is in contrast to a recent 
study that indicates that calpain 1 is a negative regulator of 
PTP1B function in platelets (  Kuchay et al., 2007  ). Our fi  ndings 
also indicate that PTP1B is a positive regulator of c-Src in breast 
cancer cells. We show that reduction of PTP1B expression in 
MTLn3 breast cancer cells enhanced phosphorylation at the 
  inhibitory tyrosine 529 and reduced endogenous c-Src activity. 
Accordingly, PTP1B inhibition impaired invadopodia formation 
in breast cancer cells, identifying PTP1B as novel component of 
the signaling machinery involved in regulating invadopodia for-
mation. Collectively, these fi  ndings implicate a novel pathway 
through calpain 2, PTP1B, and c-Src that regulates invadopodia 
formation in breast cancer cells. 
  Both PTP1B and calpain 2 are overexpressed in breast tu-
mors, with studies suggesting that   >  70% of human breast cancers 
overexpress PTP1B (  Wiener et al., 1994  ). Recent evidence has 
also implicated PTP1B as a key factor involved in the acceleration 
of breast cancer progression in mouse models (  Bentires-Alj and 
Neel, 2007  ;   Julien et al., 2007  ;   Tonks and Muthuswamy, 2007  ). 
For example, PTP1B depletion or inhibition impairs ErbB2-
induced mammary tumorigenesis and the development of lung 
metastasis in mouse models (  Julien et al., 2007  ). However, the 
mechanism by which PTP1B facilitates breast cancer progression 
  Figure 10.       Model for calpain 2 involvement in invadopodia dynamics.   
Integrin engagement and/or EGF receptor activation enhances calpain 
activity. Calpain cleaves PTP1B, resulting in enhanced phosphatase activity. 
PTP1B removes the inhibitory phosphate from Y529 of Src, thereby activat-
ing Src kinase activity and initiating invadopodia formation. Calpain 2 also 
functions downstream of Src kinase activity by regulating the disassembly 
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A Kozak methionine initiator sequence and a Flag tag were added to the 
N terminus of rat PTP1B, which was ampliﬁ  ed by PCR with the following 
primers: 5   -CTCGGATCCGCCACCATGGACTACAAGGACGACGATGAC-
AA  GAAGCTTGGGATGGAAATGGAGAAGGAATTCGAG-3     and 5    -CT  C-
T        AGA    CTCGAGCGGCCGCTCAGTGAAAACATACCCGGTAACAG-3    . 
The PCR product was digested with BamHI and NotI and subsequently ligated 
into the corresponding sites of pCDNA3.1(+) (Invitrogen). 
  Immunoblot analysis 
  Cells were plated in     -MEM on dishes coated with 10   μ  g/ml FN and incu-
bated at 37  °  C under 5% CO  2   for 3 h. Cells were lysed in modiﬁ  ed RIPA 
buffer (20 mM Hepes, pH 7.2, 150 mM NaCl, 2 mM EDTA, 0.5% deoxy-
cholate, 1% NP-40, 0.2 mM PMSF, 1   μ  g/ml pepstatin, 2   μ  g/ml aprotinin, 
1   μ  g/ml leupeptin, and 1 mM sodium orthovanadate) on ice and clariﬁ  ed 
by centrifugation. For phospho-Src analysis, cells were lysed in 50 mM 
Tris, pH 7.5, 1% Triton X-100, 5 mM EGTA, 150 mM NaCl, 10 mM so-
dium phosphate, 10 mM sodium ﬂ  uoride, 5 mM iodoacetic acid, 1 mM 
benzamidine, 10   μ  g/ml aprotinin, and 10   μ  g/ml leupeptin on ice for 30 min 
and clariﬁ  ed by centrifugation; then, 10 mM DTT was added to the lysate 
after protein concentration determination (  Liang et al., 2005  ). Protein con-
centrations were determined using a bicinchoninic acid protein assay kit 
(Thermo Fisher Scientiﬁ   c) according to the manufacturer  ’  s instructions. 
Equal amounts of total protein were denatured in SDS sample buffer, run 
on 4  –  20% gradient SDS-polyacrylamide gels, and transferred to nitrocellu-
lose. Western blots were imaged and quantiﬁ  ed with an infrared imaging 
system (Odyssey; LI-COR Biosciences). For analysis of cortactin cleavage, 
v-Src transformed cells were lysed and analyzed as described previously 
(  Perrin et al., 2006  ). 
  Immunoﬂ  uorescence 
  Glass coverslips were acid-washed and coated with 10   μ  g/ml FN or a 
0.2% gelatin/FN (10   μ  g/ml) mix as described previously (  Artym et al., 
2006  ). Cells were plated on coverslips in     -MEM culture medium and 
allowed to adhere for 3 h. The cell permeable PTP1B inhibitor CII was 
added to culture medium at a ﬁ  nal concentration of 500 nM. The Src 
kinase inhibitor PP2 was added to culture medium at a ﬁ  nal concentration 
of 2   μ  M. Cells were ﬁ  xed in 3.7% formaldehyde for 10 min, permeabi-
lized with 0.2% Triton X-100 for 10 min, and blocked in 5% goat serum. 
The cells were incubated with primary antibodies and rhodamine phalloi-
din for 30 min and then incubated with ﬂ  uorophore-conjugated second-
ary antibodies for 30 min. Coverslips were imaged using a 60  ×   1.40 oil 
objective on an inverted microscope (1X-70; both from Olympus) Images 
were acquired with a cooled charge-coupled device (CCD) camera 
(CoolSNAP fx; Photometrics) and captured into MetaVue imaging soft-
ware v6.2 (MDS Analytical Technologies). Error bars in all ﬁ  gures repre-
sent the SEM of at least three different determinations. 50  –  100 cells were 
counted in each determination. Cells were scored as positive for invado-
podia formation if dotlike structures contained both cortactin and actin or 
actin and p34-Arc, and were quantiﬁ  ed by counting the number of struc-
tures per cell. 
  Protein expression and puriﬁ  cation 
  PCR primers (5    -AAACTCGAGATGGAGATCGAGAAG-3     and 5    -GGGGG-
TACCTCAATGAAAACATAC-3    ) containing XhoI and KpnI sites were used to 
generate the PTP1B sequence for insertion into the pTrcHis vector (Invitrogen). 
To generate PTP1B C-terminal truncations, stop codons were introduced at 
amino acid 360 and 381 using site-directed mutagenesis (Stratagene). 
Native puriﬁ  cation of the fusion proteins was performed over Ni-NTA metal 
chelating sepharose using previously described methods (  Cortesio and 
Jiang, 2006  ). Purity of PTP1B pools was analyzed by silver stain (Bio-Rad 
Laboratories) according to the manufacturer  ’  s instructions. 
  Phosphatase activity assay 
  Puriﬁ  ed PTP1B activity was measured against pNPP using slow kinetics at an 
absorbance of 405 nm and a Multilabel HTS counter (Victor V; PerkinElmer). 
PTP1B (2   μ  g of puriﬁ  ed pools) was assayed in 50 mM Tris, pH 7.5, 
and 10 mM DTT containing 10 mM pNPP. To determine the effects of 
calpain 2  –  mediated cleavage of PTP1B, 2   μ  g of puriﬁ  ed PTP1B was incubated 
with or without 200 ng of puriﬁ  ed calpain 2 (EMD) for 30 min at 37  °  C be-
fore activity assay. To verify the importance of calpain 2 activity for PTP1B 
cleavage, calcium was omitted from the cleavage reaction or 200   μ  g/ml 
ALLM was added before the 30-min incubation. As a control, 2 mM sodium 
orthovanadate was added to activity assay to verify measured activity was 
caused by a phosphatase. To determine the effects of in vivo PTP1B proteol-
ysis on PTP1B activity, FLAG-PTP1B was immunoprecipitated from equal 
  Materials and methods 
  Reagents 
  FN was puriﬁ  ed from human plasma by afﬁ  nity chromatography as de-
scribed previously (  Ruoslahti et al., 1982  ).     -MEM, Ham  ’  s F12, Oregon 
green 488 gelatin conjugate, and rhodamine phalloidin were obtained 
from Invitrogen. ALLM and ALLN were obtained from EMD and used at a 
concentration of 50   μ  g/ml. Enolase and anti-FLAG M2 agarose beads 
were obtained from Sigma-Aldrich. The cell-permeable, potent, and selec-
tive PTP1B inhibitor CII was synthesized as described previously (  Xie et al., 
2003  ). Speciﬁ  c pharmacological properties for the cell-permeable inhibi-
tor have been reported previously (  Xie et al., 2003  ;   Liang et al., 2005  ). 
Ni-NTA Superﬂ  ow was obtained from QIAGEN. pNPP was obtained from 
Santa Cruz Biotechnology, Inc.. 
  Cell culture and transfection 
  MTLn3 cells were a gift from J. Condeelis and J. Segall (Albert Einstein Col-
lege of Medicine, New York, NY). Cells were cultured in     -MEM supple-
mented with 5% FBS and antibiotics as described previously (  Segall et al., 
1996  ). HEK cells were obtained from the American Type Culture Collection 
and cultured as recommended. Transfections of MTLn3 cells were performed 
with Lipofectamine 2000 (Invitrogen) according to the manufacturer  ’  s instruc-
tions. Cells, plated at 10 
5   per well in 6-well plates, were transfected with 
2   μ  g DNA and 4   μ  l Lipofectamine 2000 for 45 min to 1 h. Cells were cultured 
for 48 h before being analyzed. Retroviral transfection was performed as 
described previously (  Franco et al., 2004a  ). Transfections of HEK cells were 
performed using calcium phosphate precipitation. In brief, 10-cm plates con-
taining HEK cells at     80% conﬂ  uency were transfected with 12   μ  g of DNA 
for 6 h. Cells were cultured for 48 h before being analyzed. 
  Antibodies and constructs 
  Anti  –  calpain 1 and 2 antibodies were obtained from Triple Point Biologics, 
Inc.; anti  –  p34-Arc (subunit of Arp 2/3), anti-Src antibody (clone GD11), and 
anti  –  phospho-tyrosine antibody (4G10) were obtained from Millipore; anti  –
  phospho-Src (Y 
529  ), anti-ERK, and anti-p38 antibodies were obtained from 
Invitrogen; anti-PTP1B was obtained from R  &  D Systems; anti-cortactin (clone 
4F11) was a gift from A. Weaver (Vanderbilt University, Nashville, TN); and 
anti-Src (clone 327), anti-vinculin (clone h-VIN1), anti-talin (clone 8d4), anti-
FLAG (clone M2), and anti-actin (clone AC-15) antibodies were obtained 
from Sigma-Aldrich. Alexa Fluor 680 goat anti  –  mouse IgG secondary anti-
body and anti-GFP antibody was obtained from Invitrogen. IRDye 800CW 
goat anti  –  rabbit IgG secondary antibody was obtained from Rockland 
Immunochemicals, Inc. Anti  –  mouse IgG (ChromaPure, whole molecule) was 
obtained from Jackson ImmunoResearch Laboratories. Rhodamine red-X 
goat anti  –  mouse IgG was obtained from Invitrogen. 
  Constructs and siRNA 
  The pSUPER.retro (Oligoengine) RNA interference system was used to 
achieve stable expression of siRNAs. Oligonucleotides targeted to calpain 2 
or PTP1B mRNA as well as a nonsilencing control were synthesized by 
Integrated DNA Technologies, annealed, and cloned into the pSUPER.
retro.puro vector according to manufacturer  ’  s instructions. Retroviral trans-
fection was performed as described previously (  Franco et al., 2004a  ). 
Wild-type MTLn3 cells were infected at 32  °  C for 6 h and allowed to recover 
in growth medium for 24 h before selection with 1   μ  g/ml puromycin for 
4  –  5 d. Target sequences for calpain 2 in MTLn3 cells: control, 5    -TTCTCC-
GAACGTGTCACGT-3    ; Capn2 si-A, 5    -AGGCCTATGCCAAGATCAA-3    ; 
and Capn2 si-B, 5    -GAATGGCGATTTCTGCATC-3    . Target sequences for 
PTP1B in MTLn3 cells: PTP1B si-A, 5    -GCTGACACTGATCTCTGAA-3    ; and 
PTP1Bsi-B, 5    -CAGGAGGAG  CCTTGGTGTC-3    . Target sequences for hu-
man calpain 2 have been described previously (  Su et al., 2006  ). Target se-
quences for cortactin: control, 5    -TTCTCCGAACGTGTCACGT-3    ; cortactin 
si-A, 5    -CAGATGTGGAAAGCTTCTG-3    ; and cortactin si-B, 5    -CGCTTC-
GAGAGAATGTCTT-3    . The FPGV v-Src construct was a gift from M. Frame 
(University of Glasgow, Glasgow, Scotland). The enhanced GFP (EGFP)-
PTP1B-HA construct was a gift from C. Arregui (University of San Martin, 
Buenos Aires, Argentina). LCNX  –  c-Src was a gift from P. Keely (University 
of Wisconsin, Madison, WI) and a GFP tag was added to the N terminus, 
which was ampliﬁ  ed by PCR with the following primers: 5   -ACTCAGATCTAT-
GGGGAGCAGCAAGAGC-3     and 5    -CTCAGAATTCCTATAGGTTCTCTC-
CAGG-3    . EGFP-actin was obtained from Clontech Laboratories, Inc. 
EGFP-cortactin and calpain-resistant EGFP-cortactin D28 have been de-
scribed previously (  Perrin et al., 2006  ). RcRSV-cSrcY527F was a gift from 
A. Reynolds (Vanderbilt University, Nashville, TN) and was excised with 
ApaI and EcoRI and subsequently religated into pCDNA 3.1(+) (Invitrogen). JCB • VOLUME 180 • NUMBER 5 • 2008  970
volumes for Western blot analysis or a kinase assay. For immunoblot analy-
sis, immunoprecipitated Src was extracted from beads with Laemmli SDS 
sample buffer and boiling for 10 min. Samples were run on an 8% SDS-
polyacrylamide gel and transferred to nitrocellulose. Western blots were 
imaged and quantiﬁ  ed with an Odyssey infrared imaging system. Kinase 
assays were performed as described previously (  Chang et al., 1998  ) and 
were terminated with Laemmli SDS sample buffer and boiling for 10 min. 
Reactions were then run on an 8% SDS-polyacrylamide gel, dried, and 
exposed to a phosphoimage screen for 15  –  20 h. 
  In vivo calpain 2 proteolysis of PTP1B 
  HEK or MTLn3 cells were transfected with EGFP-PTP1B-HA and FLAG-PTP1B, 
respectively. HEK cells were lysed 48 h later with 50 mM Tris, pH 7.6, 
0.5 M NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, and 
0.5 mM MgCl  2  . MTLn3 cells were lysed 48 h later with 50 mM Hepes, 
pH 7.2, 0.25 M sucrose, 5 mM EDTA, and 1% Triton X-100. Calpain activ-
ity was stimulated before lysis using 1   μ  M ionomycin (Sigma-Aldrich) and 
10 mM CaCl  2  . Calpain 2  –  dependent talin cleavage has been described 
previously (  Franco et al., 2004b  ) and was used as a positive control. 
  Statistics 
  For statistical comparison, the two-tailed, paired   t   test or one-way analy-
sis of variance (ANOVA) test were used, with p-values of   <  0.05 consid-
ered signiﬁ  cant. 
  Online supplemental material 
  Fig. S1 corresponds to   Fig. 3 B   and demonstrates levels of transiently ex-
pressed GFP-cortactin in control and calpain 2 siRNA-expressing MTLn3 
cells. Fig. S2 corresponds to   Fig. 4 B   and demonstrates the rescue of inva-
dopodia formation in MTLn3 cells stably expressing cortactin siRNA using 
p34-Arc as an invadopodia marker. Fig. S3 demonstrates that inhibition 
of Src kinase activity with PP2 abolishes invadopodia formation in MTLn3 
cells. Fig. S4 corresponds to   Fig. 5   and demonstrates that the constitutively 
active c-Src mutant Y527F can rescue invadopodia formation in calpain 2  – 
deﬁ  cient cells, whereas wild-type c-Src cannot. Fig. S5 corresponds to 
  Fig. 5  and demonstrates decreased cortactin proteolysis in v-Src transformed 
MTLn3 cells expressing calpain 2 siRNA compared with control cells. Video 1 
shows dynamics of GFP-actin containing invadopodia in MTLn3 control 
cells. Video 2 shows dynamics of GFP-actin containing invadopodia in 
MTLn3 calpain 2 knockdown cells. Video 3 shows dynamics of GFP-cortactin 
containing invadopodia in MTLn3 control cells. Video 4 shows dynamics 
of GFP-cortactin containing invadopodia in MTLn3 calpain 2 knockdown 
cells. Video 5 shows dynamics of invadopodia in MTLn3 cortactin knock-
down cells expressing wild-type GFP-cortactin. Video 6 shows dynamics 
of invadopodia in MTLn3 cortactin knockdown cells expressing calpain-
resistant GFP-cortactin D28. Video 7 shows dynamics of GFP-cortactin con-
taining invadopodia in v-Src transformed MTLn3 control cells. Video 8 shows 
dynamics of GFP-cortactin containing invadopodia in v-Src transformed 
MTLn3 calpain 2 knockdown cells. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200708048/DC1. 
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